Baas et al described a spinal cord astrocytoma from a biallelic PMS2 mutation carrier with loss of MLH1 in tumor cells, probably as a result of somatic alteration, with lack of PMS2 staining in tumor and normal tissue [8]. Here, MLH1 is linked to spinal cord astrocytoma.